Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Genetics

What Is the Recurrence Risk for Holoprosencephaly?

At a Glance

The recurrence risk for holoprosencephaly (HPE) ranges from 1% for random chromosomal errors to 50% if a parent carries a specific gene mutation. Genetic counseling and testing both parents are essential to determine your family's exact risk and explore preventive options like IVF.

If you are planning to have another baby after having a child with holoprosencephaly (HPE), it is entirely natural to wonder if it will happen again, and what you can do to prevent it. The chances of having another child with HPE depend on the underlying cause, which can be genetic or environmental.

The recurrence risk for future pregnancies ranges from less than 1% to as high as 50% [1]. It is incredibly important to remember that random genetic errors or chromosomal changes are not caused by anything you did or didn’t do during your pregnancy.

To understand your specific recurrence risk and your family planning options, it is helpful to know which of the following scenarios applies to your family:

Chromosomal Causes: Generally a Low Risk

In many cases, HPE is caused by a chromosomal abnormality, such as Trisomy 13 (having three copies of chromosome 13 instead of two). These types of numerical chromosomal errors are random, one-time events that happen during the formation of an egg or sperm [1].

If your child’s HPE was caused by a random chromosomal abnormality like Trisomy 13, and both parents have normal chromosomes, the recurrence risk for future pregnancies is low—around 1% [2]. This risk is only slightly higher than the general population.

Gene Mutations: Up to a 50% Risk

Sometimes, HPE is caused by a spelling mistake in a single gene that provides instructions for early brain development. Common genes linked to HPE include SHH, ZIC2, and SIX3.

If one parent carries a mutation in one of these HPE-associated genes, there is up to a 50% chance in each pregnancy of passing that mutation on to the baby [1][3].

However, genetic inheritance with HPE can be highly unpredictable due to two important concepts [4]:

  • Variable expressivity: People with the exact same gene mutation can have very different symptoms. A parent carrying an HPE mutation might only have minor physical signs (called microforms), such as a single central front tooth, closely set eyes, or a poor sense of smell [5]. Their child, however, might inherit the same mutation and have severe HPE.
  • Incomplete penetrance: Sometimes, a person can inherit the gene mutation but show absolutely no signs or symptoms of the condition at all [4].

Because of these factors, a parent might be a “silent” carrier of an HPE gene mutation without ever realizing it.

Environmental Causes: Maternal Diabetes

While many causes of HPE are genetic, the environment in the womb during the very first weeks of pregnancy also plays a significant role. Maternal pregestational diabetes (diabetes that exists before pregnancy) is a major risk factor, increasing the chance of HPE up to 200 times compared to the general population [6][7].

If your previous child’s HPE was linked to pregestational diabetes, the recurrence risk in a future pregnancy is strongly tied to your glycemic (blood sugar) control [7]. Working with your medical team to tightly control your blood sugar before conception and during the first trimester can significantly lower the risk of HPE happening again [8].

“New” (De Novo) Mutations

If genetic testing shows that your child has a gene mutation, but high-sensitivity testing of both parents shows that neither parent carries the mutation in their blood, it is called a de novo (new) mutation [9].

In these cases, the mutation happened for the first time in the child. The recurrence risk drops significantly and is very low. However, it is not exactly zero. There is a rare phenomenon called germline mosaicism, where the mutation exists only in a parent’s reproductive cells (eggs or sperm) but not in their blood [10][9]. Because of this small possibility, specialists still offer prenatal screening in future pregnancies.

Unexplained (Idiopathic) Cases

Sometimes, even after exhaustive genetic testing, doctors cannot find the exact cause of a child’s HPE. In these idiopathic cases, where both chromosomal and single-gene testing come back normal, the empirical recurrence risk for future pregnancies is generally estimated at approximately 2% to 5% [3][9]. This accounts for the possibility of undetected low-level mosaicism or complex interactions between multiple minor genetic and environmental factors [11][12].

Why Counseling and Testing Are Critical

Because the recurrence risk can be as low as 1% or as high as 50%, working with a genetic counselor or medical geneticist is absolutely essential for family planning [1]. This testing process typically takes a few weeks to several months and involves:

  1. Testing the affected child first to identify the specific genetic or chromosomal cause.
  2. Testing both parents (via blood or saliva) to see if either carries the genetic change.
  3. A thorough physical exam of the parents to look for mild signs (microforms) of HPE [13].

Proactive Options for Future Pregnancies

If a specific genetic mutation is identified in your family, you may have proactive reproductive options to prevent passing the condition on. In Vitro Fertilization (IVF) with Preimplantation Genetic Testing (PGT-M) allows doctors to test embryos for the specific familial mutation before they are transferred to the uterus [9][14]. This can reduce the risk of having another affected pregnancy to near zero.

Common questions in this guide

Will I have another child with holoprosencephaly?
The chances depend heavily on the underlying cause of your previous child's condition. If it was caused by a random chromosomal error, the recurrence risk is about 1%, but if a parent carries a specific gene mutation, the risk can be up to 50% for each pregnancy.
Can I be a carrier for holoprosencephaly without having any symptoms?
Yes, it is possible to carry an HPE gene mutation without knowing it. Some people show absolutely no signs of the condition, while others may only have very subtle physical features like a single front central tooth, closely set eyes, or a poor sense of smell.
Does maternal diabetes increase the risk of holoprosencephaly?
Yes, poorly controlled maternal diabetes that exists before pregnancy is a major risk factor. Tightly controlling your blood sugar levels before conception and during the first trimester can significantly lower the chances of the condition happening again.
Can IVF help prevent holoprosencephaly in future pregnancies?
If genetic testing identifies a specific HPE mutation in your family, doctors can use in vitro fertilization (IVF) paired with preimplantation genetic testing (PGT-M). This allows them to screen embryos for the mutation before pregnancy begins, reducing the risk to near zero.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What specific genetic testing (such as a microarray or an HPE gene panel) was performed for my child, and do we have conclusive results?
  2. 2.Do you recommend physical exams and high-sensitivity genetic testing for my partner and me to rule out subtle features or low-level mosaicism?
  3. 3.Given our specific diagnostic results (or lack thereof), what is our exact personalized recurrence risk?
  4. 4.Are we candidates for IVF with Preimplantation Genetic Testing (PGT-M) based on our family's genetic findings?
  5. 5.What proactive steps, such as optimizing my blood sugar levels or taking specific supplements, should I take before trying to conceive again?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Recent advances in the diagnosis and molecular pathogenesis of holoprosencephaly: a review.

    Glista F, Nienartowicz J, Bukowska-Olech E

    Journal of applied genetics 2025; doi:10.1007/s13353-025-01017-8.

    PMID: 41102431
  2. 2

    Holoprosencephaly: A clinical genomics perspective.

    Solomon BD, Retterer K, Juusola J

    American journal of medical genetics. Part C, Seminars in medical genetics 2018; (178(2)):194-197 doi:10.1002/ajmg.c.31613.

    PMID: 29749690
  3. 3

    Recent advances in understanding inheritance of holoprosencephaly.

    Dubourg C, Kim A, Watrin E, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2018; (178(2)):258-269 doi:10.1002/ajmg.c.31619.

    PMID: 29785796
  4. 4

    A forebrain undivided: Unleashing model organisms to solve the mysteries of holoprosencephaly.

    Grinblat Y, Lipinski RJ

    Developmental dynamics : an official publication of the American Association of Anatomists 2019; (248(8)):626-633 doi:10.1002/dvdy.41.

    PMID: 30993762
  5. 5

    SIX3 deletions and incomplete penetrance in families affected by holoprosencephaly.

    Stokes B, Berger SI, Hall BA, et al.

    Congenital anomalies 2018; (58(1)):29-32 doi:10.1111/cga.12234.

    PMID: 28670735
  6. 6

    Are the prevalence of Trisomy 13 and the incidence of severe holoprosencephaly increasing in Africa?

    Okoye JO, Ngokere AA

    Prenatal diagnosis 2020; (40(12)):1616-1617 doi:10.1002/pd.5777.

    PMID: 32715507
  7. 7

    The rare malformation holoprosencephaly: pathogenesis, association with pregestational diabetes and the possible link with food pollutants.

    Taruscio D, Mantovani A

    Annali dell'Istituto superiore di sanita 2023; (59(4)):295-303 doi:10.4415/ANN_23_04_09.

    PMID: 38088397
  8. 8

    Identifying environmental risk factors and gene-environment interactions in holoprosencephaly.

    Addissie YA, Troia A, Wong ZC, et al.

    Birth defects research 2021; (113(1)):63-76 doi:10.1002/bdr2.1834.

    PMID: 33111505
  9. 9

    Low-level parental mosaicism affects the recurrence risk of holoprosencephaly.

    Hu P, Martinez AF, Kruszka P, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(4)):1015-1020 doi:10.1038/s41436-018-0261-8.

    PMID: 30197418
  10. 10

    De Novo Heterozygous GATA3 Missense Variant Causes an Unexpected Phenotype of Non-Syndromic Hearing Impairment with Apparently Recessive Inheritance.

    Domínguez-Ruiz M, Garrido G, Martínez-Beneyto P, et al.

    International journal of molecular sciences 2025; (26(13)) doi:10.3390/ijms26136363.

    PMID: 40650141
  11. 11

    Cytogenetics and holoprosencephaly: A chromosomal microarray study of 222 individuals with holoprosencephaly.

    Hu T, Kruszka P, Martinez AF, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2018; (178(2)):175-186 doi:10.1002/ajmg.c.31622.

    PMID: 30182442
  12. 12

    Complex mode of inheritance in holoprosencephaly revealed by whole exome sequencing.

    Mouden C, Dubourg C, Carré W, et al.

    Clinical genetics 2016; (89(6)):659-68 doi:10.1111/cge.12722.

    PMID: 26748417
  13. 13

    Neuropathology of holoprosencephaly.

    Fallet-Bianco C

    American journal of medical genetics. Part C, Seminars in medical genetics 2018; (178(2)):214-228 doi:10.1002/ajmg.c.31623.

    PMID: 30182440
  14. 14

    Partial monosomy 18p and 21q due to a paternal reciprocal translocation leading to holoprosencephaly.

    Wakabayashi H, Matsumoto A, Komori S, et al.

    Human genome variation 2025; (12(1)):10 doi:10.1038/s41439-025-00314-2.

    PMID: 40447572

This page provides general information about holoprosencephaly recurrence risks for educational purposes. It does not replace genetic counseling or personalized family planning advice from your maternal-fetal medicine specialist or geneticist.

Get notified when new evidence is published on Holoprosencephaly.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.